Denmark’s Chr. Hansen Holding AS will pay $530m to acquire probiotics specialist UAS Laboratories in a move the company says will strengthen its production flexibility. The deal is expected to close within three months, subject to regulatory approval in the US.
Wisconsin-based UAS – owned by private equity fund Lakeview Equity Partners – is a B2B company specializing in clinically documented...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?